Pharmafile Logo

News and Press Releases

Asceneuron Secures $100m Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases

Financing led by Novo Holdings, including new investment from EQT Life Sciences – LSP Dementia Fund, OrbiMed and SR One with participation from existing investors M Ventures, Sofinnova Partners, GSK...

Category: Biotechnology, Clinical Trials, Other
Posted: July 16, 2024

Asceneuron SA
asce-contact@asceneuron.com
Asceneuron SA, EPFL Innovation Park, Bâtiment B, CH-1015 Lausanne, Switzerland

Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development

£90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital, Cancer Research Horizons and Lilly participated alongside founding investors...

Category: BioManufacturing, Clinical Trials, Other
Posted: July 8, 2024

Myricx
info@myricxbio.com
Myricx Bio Gridiron Building, 1 Pancras Square, King’s Cross, London, N1C 4AG

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Proof-of-concept study to investigate personalised dose management of first-line anti-hypertensive in improving blood pressure control remotely Key milestone in co-development partnership to combine leading medicine brands with dose optimisation technology...

Category: Biotechnology, Clinical Trials
Posted: May 16, 2024

Closed Loop Medicine
info@closedloopmedicine.com
Babraham Research Campus Cambridge CB22 3AT United Kingdom

PlaqueTec closes $8m equity financing

The financing was led by Lord Moynihan of Chelsea alongside The Future Fund, with support from existing investors Funding will support ongoing BIOPATTERN trial and build BIOCARTA database to transform...

Category: Biotechnology, Other, Pharmaceutical
Posted: April 30, 2024

PlaqueTec
info@plaquetec.com
Maia Building (B270) Babraham Research Campus Cambridge CB22 3AT

Owlstone Medical Secures $6.5m to Support Development of Breath-based Diagnostics for Infectious Disease

$5m equity investment and initial $1.5m grant funding committed by the Bill & Melinda Gates Foundation for development of breath-based diagnostic solutions to improve outcomes in the developing world Funding...

Category: Biotechnology, Other
Posted: April 25, 2024

Owlstone Medical
breathbiopsy@owlstone.co.uk
Owlstone Ltd, 127 Cambridge Science Park, Milton Road, Cambridge, CB4 0GD, UK

Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy

EVOLUTION phase 2 trial follows successful phase 1 demonstration of proof of concept for a lung cancer screening test and safety of probe Phase 2 study to focus on assessing...

Category: Clinical Trials
Posted: October 10, 2023

Owlstone Medical
breathbiopsy@owlstone.co.uk
Owlstone Ltd, 127 Cambridge Science Park, Milton Road, Cambridge, CB4 0GD, UK